Decima Health to pitch eczema treatment at US conference

Decima Health chief executive Iona Weir

Dr Iona Weir, Decima Health chief executive, will get the chance to pitch the eczema treatment she developed to a global dermatology conference in the US after organisers liked her abstract so much they asked her to be a keynote speaker.

Dr Weir will address the International Conference on Clinical and Experimental Dermatology in Chicago in May about Atopsis, a product that grew out of her PhD in 1997 on programmed cell death in plants known as apoptosis.

Her research showed apoptosis in plants was reversible, unlike in animals, and she was able to extract "critical reactions" in plants that could be put in a cream as a topical application for skin conditions in humans, such as eczema and acne. The extract encourages the body's immune response to attack affected areas and repair damaged cells.

"By manipulating this reversibility in plants I have been able to create Atopsis to manipulate apoptosis and immune function in human cells to stimulate cell repair and growth," Dr Weir said. Clinical trials in the US and New Zealand both showed a reduction in the symptoms of eczema, opening the door for a larger US study, she said.

Dr Weir won an international award for her PhD and was able to continue her research with a grant from the Marsden Fund. A grant from Callaghan Innovation helped fund the double-blind placebo controlled clinical trial completed by Southern Clinical Trials Group at the end of 2015.

Decima has set up a subsidiary, Bionona, to pursue global partnerships for the release of Atopsis. Bionona is chaired by Paul Dallimore, former executive chairman of National Property Trust and chairman of Highgate Group.

(BusinessDesk)

BusinessDesk receives funding to help cover the commercialisation of innovation from Callaghan Innovation.


1 · Got a question about this story? Leave it in Comments & Questions below.

This article is tagged with the following keywords. Find out more about MyNBR Tags

1 Comment & Question

Commenter icon key: Subscriber Verified

Could this very interesting research subsequently be useful in treating skin cancers such as squamous cell carcinomas?

Reply
Share
  • 0
  • 0

Post New comment or question

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

NZ Market Snapshot

Forex

Sym Price Change
USD 0.7333 0.0000 0.00%
AUD 0.9160 0.0013 0.14%
EUR 0.6176 -0.0001 -0.02%
GBP 0.5439 0.0002 0.04%
HKD 5.7225 0.0036 0.06%
JPY 82.4590 -0.0760 -0.09%

Commods

Commodity Price Change Time
Gold Index 1301.0 -9.900 2017-09-20T00:
Oil Brent 56.3 1.090 2017-09-20T00:
Oil Nymex 50.7 1.150 2017-09-20T00:
Silver Index 17.3 0.055 2017-09-20T00:

Indices

Symbol Open High Last %
NZX 50 7851.1 7851.1 7819.2 -0.42%
NASDAQ 6459.7 6466.1 6461.3 -0.08%
DAX 12550.9 12593.2 12561.8 0.06%
DJI 22351.4 22413.3 22370.8 0.19%
FTSE 7275.2 7289.9 7275.2 -0.05%
HKSE 28091.2 28184.4 28127.8 0.10%
NI225 20456.5 20481.3 20310.5 0.45%
ASX 5709.1 5709.1 5709.1 -0.88%